Relmada Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US75955J4022
USD
3.60
2.77 (335.57%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryRelmada Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
335.57%
-0.51%
1W
416.28%
-1.37%
1M
758.16%
0.35%
YTD
592.31%
0.54%
1Y
15.38%
13.99%
3Y
-80%
66.39%
5Y
-92.65%
77.77%
10Y
-92.65%
259.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
1223.53%
0%
1223.53%
6 Months
666.28%
0%
666.28%
1 Year
15.38%
0%
15.38%
2 Years
35.85%
0%
35.85%
3 Years
-80.0%
0%
-80.0%
4 Years
-88.23%
0%
-88.23%
5 Years
-92.65%
0%
-92.65%

Relmada Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary